Jennison Associates
TEVA icon

Jennison Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Jennison Associates’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Sell
359,114
-1,080,037
-75% -$36M 0.01% 378
2026
Q1 		$43.3M Sell
1,439,151
-94,220
-6% -$3.03M 0.03% 241
2025
Q4 		$47.9M Buy
+1,533,371
New +$37.8M 0.03% 212
2016
Q4 		– Sell
-1,387,919
Closed -$63.9M – 829
2016
Q3 		$63.9M Sell
1,387,919
-436,250
-24% -$22.8M 0.07% 244
2016
Q2 		$91.6M Sell
1,824,169
-6,085
-0.3% -$324K 0.1% 179
2016
Q1 		$97.9M Buy
1,830,254
+25,299
+1% +$1.48M 0.1% 172
2015
Q4 		$118M Sell
1,804,955
-104,505
-5% -$6.46M 0.12% 150
2015
Q3 		$108M Buy
1,909,460
+162,612
+9% +$10.5M 0.11% 167
2015
Q2 		$103M Sell
1,746,848
-343,225
-16% -$21.2M 0.09% 197
2015
Q1 		$130M Buy
2,090,073
+172,793
+9% +$10M 0.12% 163
2014
Q4 		$110M Sell
1,917,280
-197,372
-9% -$11M 0.1% 189
2014
Q3 		$114M Sell
2,114,652
-1,807,533
-46% -$95.8M 0.11% 177
2014
Q2 		$206M Buy
3,922,185
+193,895
+5% +$9.91M 0.19% 113
2014
Q1 		$197M Buy
3,728,290
+2,699,462
+262% +$125M 0.19% 111
2013
Q4 		$41.2M Sell
1,028,828
-4,106
-0.4% -$162K 0.04% 345
2013
Q3 		$39M Sell
1,032,934
-3,264
-0.3% -$127K 0.04% 346
2013
Q2 		$40.6M Buy
+1,036,198
New +$40.4M 0.05% 321

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Jennison Associates's TEVA Position: Q2 2026 in Review

Jennison Associates reduced its Teva Pharmaceuticals (TEVA) stake by 75% in Q2 2026, selling an estimated $36M and leaving 359,114 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #378.

Jennison Associates first reported a position in TEVA in Q2 2013 and has held it in 17 quarters since. The position peaked at $206M in Q2 2014. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Jennison Associates held 359,114 shares of Teva Pharmaceuticals worth $12.2M as of Q2 2026.
  • Jennison Associates sold 1,080,037 Teva Pharmaceuticals shares in Q2 2026, an estimated $36M.
  • Teva Pharmaceuticals made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #378 holding.
  • Jennison Associates first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Jennison Associates's Teva Pharmaceuticals position peaked at $206M in Q2 2014.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.